Trial Profile
A phase 1, multicentre, open-label study assessing ovarian follicular activity and hormone levels of an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D
- 29 Mar 2016 New trial record